Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Swedencare AB (publ), an enterprise established in 1993 and headquartered in Malmö, Sweden, operates with its subsidiaries to develop, produce, market, and sell a wide array of healthcare products, predominantly for animals. The company's flagship offering is the ProDen PlaqueOff line, focused on dental hygiene for dogs and cats. This popular range includes a food supplement powder designed to reduce plaque and tartar buildup, along with various chewable formats such as dental bites, bones (including mini versions for smaller dogs), and soft chews suitable for both felines and canines. Beyond dental care, Swedencare provides an extensive selection of nutritional supplements under the NutriScience brand for cats, dogs, and horses. These products address diverse health requirements: Glucosamine and Stomax aid in the rejuvenation of joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid supports joint function and mobility; KalmAid offers a calming effect for anxious dogs; while OmegaAid and RevitalAid are formulated to promote healthy skin and coats. Furthermore, the company manufactures specialized supplements for horses, including Gastrocare to alleviate gastric pain and enhance appetite; Equine Gold for overall vitality; a horse-specific ArthriAid to assist with cartilage formation; and AnxiKalm, aimed at soothing excitable horses. Interestingly, Swedencare also caters to human health with ProDen PlaqueOff Teeth and Gums, a natural dietary supplement designed to boost oral hygiene and prevent tartar accumulation. The company's products are distributed through a broad network that includes pharmacies, veterinary clinics, pet stores, animal hospitals, and online channels.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA,
Target Price
The average target price of SECARE.ST is 41 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc